Matching trials
1,853 results
- Pediatric Tonsillectomy Pain Reduction Study: Complete Statistical AnalysisIndependent statistical analysis of Pediatric Tonsillectomy Pain Reduction Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678379).
- Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7): Complete Statistical AnalysisIndependent statistical analysis of Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer: primary endpoint results, effect estimate…
- Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302): Complete Statistical AnalysisIndependent statistical analysis of Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307): Complete Statistical AnalysisIndependent statistical analysis of Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PEOPLEComplete statistical analysis of the PEOPLE phase 3 trial of post-exposure prophylaxis for leprosy in the Comoros and Madagascar, including trial design, incidence rate ratios, mixed-effects methodology, confidence intervals, and interpretation.
- PEOPLEIndependent statistical analysis of Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03662022).
- PerformsIndependent statistical analysis of A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01036165).
- Pericoital Oral Contraception With Levonorgestrel: Complete Statistical AnalysisIndependent statistical analysis of Pericoital Oral Contraception With Levonorgestrel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00922233).
- Peripheral Dopamine in Postural Tachycardia Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Peripheral Dopamine in Postural Tachycardia Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00685919).
- PERSEPHONEIndependent statistical analysis of the PERSEPHONE phase 3 trial evaluating lunsekimig compared with placebo in adults with inadequately controlled eosinophilic chronic obstructive pulmonary disease. Includes trial design, endpoints, statistical methodology, planned analysis,…
- PERSISTIndependent statistical analysis of Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01358357).
- Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines: Complete Statistical AnalysisIndependent statistical analysis of Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size…
- PERUSEIndependent statistical analysis of A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer: primary…
- PETACC-3An independent statistical analysis of PETACC-3, a randomized phase 3 trial evaluating fluorouracil and leucovorin with or without irinotecan following surgery for stage III colorectal cancer.
- PETACC-6Independent statistical analysis of PETACC-6, a phase 3 randomized trial evaluating capecitabine with or without oxaliplatin after chemoradiation and before surgery in locally advanced rectal cancer. Includes trial design, endpoints, statistical methodology,…
- PFA and SPFIndependent statistical analysis of Determination of Sun Protection in Sunscreen Formulas (Study SR09-15)(P08236)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01001975).
- Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02884908).
- Pharmacogenetics of Nicotine Addiction Treatment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenetics of Nicotine Addiction Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01314001).
- Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00701636).
- Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD): primary endpoint results, effect estimate with confidence…
- Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo: primary…
- Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL): Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Phase 3 Papulopustular Rosacea Study: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Papulopustular Rosacea Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01493687).
- Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase III Cat-PAD Follow-on Study: Complete Statistical AnalysisIndependent statistical analysis of Phase III Cat-PAD Follow-on Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02040844).
- Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas: Complete Statistical AnalysisIndependent statistical analysis of Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size…
- PICCOLOIndependent statistical analysis of the PICCOLO phase 3 trial of irinotecan with or without panitumumab or cyclosporine in advanced or metastatic colorectal cancer that did not respond to fluorouracil.
- Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression: Complete Statistical AnalysisIndependent statistical analysis of Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PinPointe FootLaser for the Treatment of Onychomycosis: Complete Statistical AnalysisIndependent statistical analysis of PinPointe FootLaser for the Treatment of Onychomycosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00935649).
- PIONEER 4Independent statistical analysis of Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PIONEER 6Independent statistical analysis of PIONEER 6, the randomized phase 3 trial of oral semaglutide versus placebo in subjects with type 2 diabetes, including its MACE endpoint, non-inferiority analysis, Cox model, hazard ratio,…
- PIONEER AF-PCIIndependent statistical analysis of A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention: primary endpoint…
- PIONEER PLUSA detailed statistical analysis of the randomized phase 3 PIONEER PLUS trial comparing three once-daily doses of oral semaglutide in people with type 2 diabetes, including the registered HbA1c endpoint, ANCOVA methodology,…
- Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pivotal Study in Advanced Parkinsons Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study in Advanced Parkinsons Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466167).
- Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months: Complete Statistical AnalysisIndependent statistical analysis of Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to
- PIX-RIndependent statistical analysis of Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are…
- Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye: Complete Statistical AnalysisIndependent statistical analysis of Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PLATINUM QCAIndependent statistical analysis of A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PLUSIndependent statistical analysis of Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke: primary endpoint results, effect estimate with confidence interval,…
- Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines: Complete Statistical AnalysisIndependent statistical analysis of Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…